From the browser to the back end, the ‘boring’ choice is exciting again. We look at three trends converging to bring SQL back ...
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable ...
In a report released today, Matt Miksic from Barclays maintained a Buy rating on InMode, with a price target of $21.00. According to TipRanks, Miksic is a 4-star analyst with an average return of 4.6% ...
Total Revenue (Q4 2025): $103.9 million, up from $97.9 million in Q4 2024. Total Revenue (Full Year 2025): $370.5 million, a 6% decrease compared to 2024. International Sales (Q4 2025): $48.5 million, ...
YOKNEAM, Israel (AP) — YOKNEAM, Israel (AP) — InMode Ltd. (INMD) on Tuesday reported net income of $27 million in its fourth quarter. The Yokneam, Israel-based company said it had net income of 42 ...
InMode ( (INMD)) has issued an announcement. On February 2, 2026, InMode issued a statement responding to market speculation surrounding a publicly announced non-binding proposal from Steel Partners ...
The MarketWatch News Department was not involved in the creation of this content. YOKNEAM, Israel, Feb. 3, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative ...
Jan 28 (Reuters) - Investment firm Steel Partners said on Wednesday it had offered $18 per share to acquire a 51% stake in InMode (INMD.O), opens new tab, sending the Israel-based medical technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results